Chas Roades is chief research officer of The Advisory Board Company. In this capacity, he studies the market forces and trends driving the evolution of the American health care industry, and directs research into ongoing changes in the organization and management of American medicine. Principal author of more than 40 landmark strategy publications for hospitals and health systems, Mr. Roades is a nationally-recognized authority on the future of health care, hospital-physician alignment, emerging reimbursement and incentive models, and the intersection of national health policy and delivery system strategy.
Mr. Roades has presented at over 100 national conferences and serves as strategic advisor to several major health systems. At over 200 national and regional meetings for Advisory Board members, Mr. Roades has addressed thousands of hospital CEOs, executive team members, and board members. He is a frequently-cited expert in leading national media outlets, including The Wall Street Journal, The New York Times, National Public Radio, and The Washington Post.
At the firm for more than a dozen years, Mr. Roades leads a research staff of over 150 and is a member of the Advisory Board’s senior leadership team. Before joining the firm, he was an engagement manager at McKinsey & Company, a management consultancy. In this role, he was responsible for leading engagements on strategy, organization, and operations for Fortune 500 clients. Previously, Mr. Roades served for five years as an officer in the United States Air Force. He is also active on hospital, nonprofit, and governmental advisory boards, and serves as an adjunct faculty member in health care administration at Brown University.
Mr. Roades earned his MBA from Stanford University. He also holds a master’s degree from Stanford, and a bachelor’s degree in economics from the University of Virginia. Mr. Roades resides in the Virginia suburbs of Washington, D.C., with his wife and their four children.
Chas Roades examines the critical questions executives must consider as they navigate the industry's move toward value-based care.
Chas Roades, chief research officer, discusses the Advisory Board's Medicare Breakeven Project.